| Product NDC: | 0338-1007 |
| Proprietary Name: | Dopamine Hydrochloride and Dextrose |
| Non Proprietary Name: | Dopamine Hydrochloride |
| Active Ingredient(s): | 160 mg/100mL & nbsp; Dopamine Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0338-1007 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019615 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120125 |
| Package NDC: | 0338-1007-03 |
| Package Description: | 500 mL in 1 BAG (0338-1007-03) |
| NDC Code | 0338-1007-03 |
| Proprietary Name | Dopamine Hydrochloride and Dextrose |
| Package Description | 500 mL in 1 BAG (0338-1007-03) |
| Product NDC | 0338-1007 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dopamine Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120125 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | DOPAMINE HYDROCHLORIDE |
| Strength Number | 160 |
| Strength Unit | mg/100mL |
| Pharmaceutical Classes | Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |